Enzene Biosciences Limited - Company Profile

Q: Who are the current directors of Enzene Biosciences Limited?

The current directors of Enzene Biosciences Limited are Sudha Ravi, Aniruddha Singh, Sangeeta Kapil Jit Singh, Prem Venkatachalam Pavoor, Himanshu Shashikant Gadgil, Sandeep Singh, Vikas Gupta, Yogita Arun Hanamshet, Nilesh Ambani.

It is a life sciences public limited company based in Pune, Maharashtra, India, established in 2006.

2006 Pune, Maharashtra, India Active

Last Updated: December 25, 2025

Access Report

About Enzene Biosciences Limited

Enzene Biosciences Limited, a active public limited company, was established on 28 August 2006 in Pune, Maharashtra, India. Engaging in biotechnology within the manufacturing sector, it holds CIN: U24232PN2006PLC165610. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹66.00 Cr and a paid-up capital of ₹51.39 Cr.

Formerly known as Enzene Biosciences Private Limited. It upholds a compliant status. Employing 665 professional, Its leadership includes Sudha Ravi (Director), Aniruddha Singh (Additional Director), Sangeeta Kapil Jit Singh (Director). Past directors included Ravindra Yogesh Shenoy, Sudha Ravi, Sangeeta Kapil Jit Singh. It holds ₹157.37 Cr open charges and ₹137.95 Cr settled loans. Its latest AGM occurred on 22 August 2025, with the balance sheet filed on 31 March 2025. It is based at Plot No A 22, A/1/2 Chakan Industrial Area, Phase 2, Khalumbre, Chakan, Pune, Maharashtra, 410501.

Company Details

CIN/LLPIN
U24232PN2006PLC165610
Registration Number
165610
Incorporation Date
28 August 2006
Authorized Capital
₹66.00 Cr
Paid-Up Capital
₹51.39 Cr
ROC Code
Roc Pune
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 66.00 Cr as on 25-12-2025
Paid Up Capital ₹ 51.39 Cr as on 25-12-2025
Company Age 19 Year, 5 Months
Last Filing with ROC 31 Mar 2025
Open Charges ₹ 157.37 Cr as on 25-12-2025
Satisfied Charges ₹ 137.95 Cr as on 25-12-2025

Comprehensive Company Insights

Explore comprehensive insights into Enzene Biosciences Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Enzene Biosciences Limited?

Current Directors

Name	Designation	Appointment Date	Status
Sudha Ravi	Director	09 Feb 2017	Current
Aniruddha Singh	Additional Director	07 Mar 2025	Current
Sangeeta Kapil Jit Singh	Director	02 Aug 2022	Current
Prem Venkatachalam Pavoor	Director	30 Jan 2023	Current
Himanshu Shashikant Gadgil	Ceo	02 Feb 2022	Current
Sandeep Singh	Director	20 Oct 2011	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Director	01 Apr 2014	Past
Pramod Abcsdd	Additional Director	19 Aug 2022	Past
Pramod Abcsdd	Additional Director	19 Aug 2022	Past
Pramod Abcsdd	Additional Director	11 Jul 2022	Past
Pramod Abcsdd	Additional Director	21 Mar 2023	Past
Pramod Abcsdd	Managing Director	01 Apr 2014	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Enzene Biosciences.

Enzene Biosciences Limited, for the financial year ended 2025, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

*******

Revenue from Operations

*******

Total Assets

*******

Profit or Loss

*******

Net Worth

*******

EBITDA

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Enzene Biosciences?

In 2024, Enzene Biosciences had a promoter holding of 99.76% and a public holding of 0.24%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹1,573,700,000.00

Satisfied Charges

₹1,379,500,000.00

Charges Breakdown by Lending Institutions

Others : 80.00 Cr
Axis Bank Limited : 77.12 Cr
Hdfc Bank Limited : 0.25 Cr

Latest Charge Details

Date	Lender	Amount	Status
16 Feb 2024	Others	₹80.00 Cr	Open
31 May 2018	Axis Bank Limited	₹77.12 Cr	Open
28 Mar 2018	Hdfc Bank Limited	₹2.50 M	Open
16 Dec 2022	Others	₹43.75 Cr	Satisfied
19 Apr 2017	Axis Bank Limited	₹45.14 Cr	Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Enzene Biosciences?

Enzene Biosciences has a workforce of 665 employees as of Dec 25, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Enzene Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Enzene Biosciences's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Enzene Biosciences

Recent Activity within the Organization

Charges

A charge registered on 16 Dec 2022 via Charge ID 100699653 with Others was fully satisfied on 18 Sep 2025. was recorded as a recent event.
18 Sep 2025
Annual General Meeting

The activity Enzene Biosciences Limited last Annual general meeting of members was held on 22 Aug 2025 as per latest MCA records. was completed.
22 Aug 2025
Director Appointment

Progress on Vikas Gupta was appointed as a Additional Director was appointed as a Additional Director on 14 Aug 2025 & has been associated with this company since 6 months 4 days . was documented.
14 Aug 2025
Balance Sheet

The activity Enzene Biosciences Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Pune. was completed.
31 Mar 2025
Director Appointment

Progress on Nilesh Ambani was appointed as a Cfo was appointed as a Cfo on 28 Mar 2025 & has been associated with this company since 10 months 20 days . was documented.
28 Mar 2025
Director Appointment

The activity Aniruddha Singh was appointed as a Additional Director was appointed as a Additional Director on 07 Mar 2025 & has been associated with this company since 11 months 11 days . was completed.
07 Mar 2025

Explore recent activity and updates - View Recent Activity